Pa. Kiener et al., Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors, INT IMMUNO, 1(1), 2001, pp. 105-118
The enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase cataly
ses the rate limiting step in cholesterol biosynthesis and is markedly inhi
bited by the statin family of drugs. The effect of statins on lipid lowerin
g is clearly defined, bur the ability of the drugs to directly regulate inf
lammatory functions has not been well explored. In this report, we show tha
t there are differences among the statins in their capacity to induce proin
flammatory responses both in human monocytes in vitro, and in leukocytes in
mice in vivo. Treatment of human monocytes with lipophilic statins alone s
timulated the production of MCP-1, IL-8, TNF-alpha and IL-1 beta and marked
ly sensitized the cells to subsequent challenge with inflammatory agents. L
ipophilic statins also increased the production of reactive oxygen species
in monocytes. In contrast, pretreatment of cells with the hydrophilic prava
statin did not induce these heightened inflammatory responses. Furthermore,
treatment of mice with lipophilic statins caused a markedly higher influx
of leukocytes into the inflamed peritoneal cavity following challenge with
thioglycollate. Overall, these results demonstrate that the lipophilic stat
ins influence a regulatory pathway in monocytes that controls cytokine prod
uction and that the statins induce different pro-inflammatory responses bot
h in vitro and in vivo. (C) 2001 Elsevier Science B.V. All rights reserved.